1221793-66-3 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
4,6-Difluoro-1H-benzo[d]imidazol-2(3H)-one is used as a research compound for its potential applications in the development of new pharmaceuticals. Its unique structure and properties make it a candidate for the treatment of various diseases and disorders.
Used in Anti-Cancer Applications:
In the field of oncology, 4,6-Difluoro-1H-benzo[d]imidazol-2(3H)-one is used as a potential anti-cancer agent. Studies have indicated its effectiveness in targeting and combating cancer cells, suggesting its utility in the creation of novel therapeutics for cancer treatment.
Used in Anti-Inflammatory Applications:
4,6-Difluoro-1H-benzo[d]imidazol-2(3H)-one is also utilized as an anti-inflammatory agent. Its properties may contribute to the management of inflammation, which is a common factor in many diseases and conditions.
Used in Antimicrobial Applications:
Furthermore, 4,6-Difluoro-1H-benzo[d]imidazol-2(3H)-one has demonstrated antimicrobial activity, making it a candidate for use in the development of new antibiotics or antifungal agents to combat microbial infections.
Used in Medicinal Chemistry:
In the broader scope of medicinal chemistry, 4,6-Difluoro-1H-benzo[d]imidazol-2(3H)-one is used as a target for further research and development. Its exploration can lead to advancements in understanding the molecular mechanisms of diseases and the discovery of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1221793-66-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,1,7,9 and 3 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1221793-66:
(9*1)+(8*2)+(7*2)+(6*1)+(5*7)+(4*9)+(3*3)+(2*6)+(1*6)=143
143 % 10 = 3
So 1221793-66-3 is a valid CAS Registry Number.
1221793-66-3Relevant articles and documents
BENZIMIDAZOLE DERIVATIVES AND THEIR USES
-
Page/Page column 24, (2020/10/21)
The present invention provides compounds which inhibit the activity of TRPC6, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
BENZIMIDAZOLE DERIVATIVES AND THEIR USES
-
Page/Page column 97-98, (2019/05/10)
The present invention relates to inhibitors of Transient Receptor Potential Channel 6 (TRPC6) protein activity. The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising